Cambridge Innovation Capital

Get funding

Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation.

Use: Go2Market;
Date closing: -
Amount: -
Industry focus: All
Total budget: 264M €
Entity type: Venture Capital
Vertical focus: deep tech, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics
Website: https://www.cic.vc/

Status:
Open
Funding type: Equity investment;
Geographic focus: United Kingdom;
Public/Private: Private
Stage focus: Seed; Series A;
Applicant target: Startup;

Add a Review Send question

Overview

CIC backs life sciences and technology companies in Europe’s leading ecosystem, Cambridge. A preferred investor for the university.

They invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics. They provide early stage capital to disruptive, deep technology companies and life sciences businesses in therapeutics, medtech/diagnostics, digital health and genomics/proteomics.

Cambridge Innovation Capital has raised a total of $640.3M across 2 funds, their latest being Fund II. This fund was announced on Apr 26, 2022 and raised a total of €264M.

Applicants willing to get in touch with CIC can do it by following this link.

Portfolio: GeninCode, Cytora, Exvastat, Imagen.

Last updated on 2023-03-09 10:47